Operator-independent quantitative chest computed tomography versus standard assessment of interstitial lung disease related to systemic sclerosis: A multi-centric study
Authors:
- Mario SilvaMSMario Silva
- Elena BraviEBElena Bravi
- Marta SaraccoMSMarta Saracco
- Simone ParisiSPSimone Parisi
- Fabio De GennaroFGFabio De Gennaro
- Federica LumettiFLFederica Lumetti
- Luca IdolazziLILuca Idolazzi
- Valeria SelettiVSValeria Seletti
- Paola CaramaschiPCPaola Caramaschi
- Camilla BeniniCBCamilla Benini
- Flavio Cesare BodiniFBFlavio Cesare Bodini
- 12 March 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 25 (5) , 724-730
Abstract
Interstitial lung disease (ILD) related to systemic sclerosis (SSc) is assessed with pulmonary functional tests (PFTs) and semi-quantitative scores based on extent of ILD detectable on chest computed tomography (CT). CT quantitative indexes (QCTIs) are promising tools to assess extent of ILD. This study's aim is to evaluate the validity of QCTI compared with that of chest CT standard evaluation and PFTs. Moreover, QCTI differences between patients' subgroups according to prognostic stratifications were investigated. ILD-SSc of patients from six rheumatological clinics was routinely assessed with chest CT and PFTs. Patients were clustered according to prognosis based on functional and/or radiological examinations. Finally, chest CTs were processed with OsiriX in order to obtain QCTI. Two hundred fifty-seven SSc patients were enrolled. QCTI correlation between extent of ILD and PFTs range from - 0.60 to 0.58 and from - 0.54 to 0.52, respectively. The majority of QCTI have a different distribution in patients' subgroups based on prognosis. Most of QCTI discriminate patients with an ILD severity leading to a poor prognosis. QCTI assessment of ILD-SSc is comparable to the evaluation based on chest CT and/or PFTs. QCTI values corresponding to severe ILD were identified. QCTIs are excellent candidates for a new and more reliable SSc-ILD assessment.Keywords
This publication has 37 references indexed in Scilit:
- Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinantsThorax, 2013
- Mortality in systemic sclerosis—a single centre study from the UKClinical Rheumatology, 2013
- Comparison of different measures of diffusing capacity for carbon monoxide (DLCO) in systemic sclerosisClinical Rheumatology, 2013
- Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centresAnnals of the Rheumatic Diseases, 2011
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseAnnals of the Rheumatic Diseases, 2010
- Treatment of Scleroderma-Interstitial Lung Disease With Cyclophosphamide Is Associated With Less Progressive Fibrosis on Serial Thoracic High-Resolution CT Scan Than PlaceboChest, 2009
- HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalitiesLa radiologia medica, 2009
- Correlation of the degree of dyspnea with health‐related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: Results from the scleroderma lung studyArthritis & Rheumatism, 2005
- Mortality and prognostic factors in Spanish patients with systemic sclerosisRheumatology, 2003
- CT of the Lung Parenchyma and the Pulmonary Function TestChest, 1987